KRISTEN SCHREIBER: Open Payments
NPI 1447748967 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,501 in 119 payments from 23 companies in 2025. Trend: 2023 $2,633 · 2024 $2,788 · 2025 $4,501
Food & beverage: $3,602Travel & lodging: $778Education: $121
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 10 | $1,285 |
| Ferring Pharmaceuticals Inc. | 17 | $520 |
| Janssen Biotech, Inc. | 16 | $519 |
| Sumitomo Pharma America, Inc. | 22 | $366 |
| Medtronic, Inc. | 4 | $362 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $281 |
| Dendreon Pharmaceuticals LLC | 9 | $221 |
| Procept Biorobotics Corporation | 3 | $207 |
| UROGEN PHARMA, INC. | 4 | $111 |
| Novartis Pharmaceuticals Corporation | 5 | $109 |
Products named: Axonics, ADSTILADRIN, INTERSTIM, GEMTESA, ERLEADA, Nubeqa, RYBREVANT, PROVENGE.
Industry payments across MO — which companies pay providers there.
